Paper41018706
Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in Mycobacterium avium Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score.
Hayashi M and 5 others. Open Forum Infect Dis, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in Mycobacterium avium Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score. Papers, record 41018706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41018706
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in Mycobacterium avium Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37423256 | Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease. | Chest | 2023 | https://conductscience.org/library/papers/37423256 | PubMed |
| 2 | 31611366 | Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31611366 | PubMed |
| 3 | 33796599 | Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study. | Open Forum Infect Dis | 2021 | https://conductscience.org/library/papers/33796599 | PubMed |
| 4 | 32141923 | Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals. | Crit Care Med | 2020 | https://conductscience.org/library/papers/32141923 | PubMed |
| 5 | 37022189 | Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37022189 | PubMed |
| 6 | 34793759 | Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality. | Chest | 2022 | https://conductscience.org/library/papers/34793759 | PubMed |
| 7 | 28954780 | Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. | Eur Respir J | 2017 | https://conductscience.org/library/papers/28954780 | PubMed |
| 8 | 31915013 | Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study. | Respir Res | 2020 | https://conductscience.org/library/papers/31915013 | PubMed |
| 9 | 39582505 | The Long and Winding Road: Three-year Mortality Following Prescription of Multidrug Antibiotic Treatment for Mycobacterium avium complex Pulmonary Disease in United States Medicare Beneficiaries With Bronchiectasis. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/39582505 | PubMed |
| 10 | 24059365 | Serial CT findings of nodular bronchiectatic Mycobacterium avium complex pulmonary disease with antibiotic treatment. | AJR Am J Roentgenol | 2013 | https://conductscience.org/library/papers/24059365 | PubMed |
| 11 | 35505476 | M. avium complex pulmonary disease: does the diagnostic method affect severity and progression? | Int J Tuberc Lung Dis | 2022 | https://conductscience.org/library/papers/35505476 | PubMed |
| 12 | 29567726 | Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. | Eur Respir J | 2018 | https://conductscience.org/library/papers/29567726 | PubMed |
| 13 | 34046491 | Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics. | ERJ Open Res | 2021 | https://conductscience.org/library/papers/34046491 | PubMed |
| 14 | 35748569 | Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study. | Ther Adv Respir Dis | 2022 | https://conductscience.org/library/papers/35748569 | PubMed |
| 15 | 28541556 | Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/28541556 | PubMed |
| 16 | 36244600 | Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. | Int J Infect Dis | 2022 | https://conductscience.org/library/papers/36244600 | PubMed |
| 17 | 32721164 | BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease. | Am J Respir Crit Care Med | 2021 | https://conductscience.org/library/papers/32721164 | PubMed |
| 18 | 32442113 | Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy. | Respir Med | 2020 | https://conductscience.org/library/papers/32442113 | PubMed |
| 19 | 40153596 | Intermittent versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial. | Ann Am Thorac Soc | 2025 | https://conductscience.org/library/papers/40153596 | PubMed |
| 20 | 24298907 | Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. | Ann Am Thorac Soc | 2014 | https://conductscience.org/library/papers/24298907 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984813 | Species distribution and antimicrobial susceptibility profiles of nontuberculous mycobacteria, with an exploratory 12-month completer outcome analysis: a single-center retrospective study from Shandong Province, China. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42984813 | PubMed |
| 41638757 | Clinical characteristics of pulmonary non-tuberculous mycobacterial disease with CFTR variants in the Japanese population. | BMJ Open Respir Res | 2026 | https://conductscience.org/library/papers/41638757 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41018706
GET https://conductscience.org/api/papers/v1/41018706/references?page=2